Industry: Medical Devices & Consumables
Published Date: 2024-06-15
Pages: 93 Pages
Report ld: 3198550
Request Sample
Customized Report
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) include Medtronic, Jiuyuan Gene Engineering, Cellumed, Yantai Zhenghai Bio-Tech, etc. The global five biggest players hold a share of % in 2023.
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Product Introduction
1.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Outlook 2019 VS 2023 VS 2030
1.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in US$ Million for the Year 2019-2030
1.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume for the Year 2019-2030
1.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Outlook 2019 VS 2023 VS 2030
1.3.1 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in US$ Million for the Year 2019-2030
1.3.2 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume for the Year 2019-2030
1.4 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Dynamics
1.5.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Industry Trends
1.5.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Drivers
1.5.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Challenges
1.5.4 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) by Type
2.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market by Type
2.1.1 Sponge Carrier
2.1.2 Hydroxyapatite Carrier
2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Type
2.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Type
2.3.1 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) by Application
3.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market by Application
3.1.1 Spinal Fusion
3.1.2 Trauma Surgery
3.1.3 Oral Maxillofacial Surgery
3.1.4 Reconstructive
3.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Application
3.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Application
3.3.1 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Competitor Landscape by Company
4.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Company
4.1.1 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2), Ranked by Revenue (2023)
4.1.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue by Manufacturer (2019-2024)
4.1.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales by Manufacturer (2019-2024)
4.1.4 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Price by Manufacturer (2019-2024)
4.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Concentration Ratio (CR)
4.2.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in 2023
4.2.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2), Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2), Product Offered and Application
4.5 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2), Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Company
4.7.1 Key Players of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in United States, Ranked by Revenue (2023)
4.7.2 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Revenue by Players (2019-2024)
4.7.3 United States Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales by Players (2019-2024)
5 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Region
5.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size in Volume by Region (2019-2030)
5.2.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume by Region: 2019-2024
5.2.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume Forecast by Region (2025-2030)
5.3 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size in Value by Region (2019-2030)
5.3.1 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value by Region: 2019-2024
5.3.2 Global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size YoY Growth 2019-2030
6.2 Americas Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size YoY Growth 2019-2030
7.2 EMEA Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size YoY Growth 2019-2030
8.2 China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Size YoY Growth 2019-2030
9.2 APAC Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Description and Business Overview
10.1.3 Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Medtronic Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Products Offered
10.1.5 Medtronic Recent Development
10.2 Jiuyuan Gene Engineering
10.2.1 Jiuyuan Gene Engineering Company Information
10.2.2 Jiuyuan Gene Engineering Description and Business Overview
10.2.3 Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Jiuyuan Gene Engineering Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Products Offered
10.2.5 Jiuyuan Gene Engineering Recent Development
10.3 Cellumed
10.3.1 Cellumed Company Information
10.3.2 Cellumed Description and Business Overview
10.3.3 Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Cellumed Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Products Offered
10.3.5 Cellumed Recent Development
10.4 Yantai Zhenghai Bio-Tech
10.4.1 Yantai Zhenghai Bio-Tech Company Information
10.4.2 Yantai Zhenghai Bio-Tech Description and Business Overview
10.4.3 Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Yantai Zhenghai Bio-Tech Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Products Offered
10.4.5 Yantai Zhenghai Bio-Tech Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Industry Chain Analysis
11.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Production Mode & Process
11.4 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales and Marketing
11.4.1 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Sales Channels
11.4.2 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Distributors
11.5 Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 110
USD 4900.00
(Single User License)
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 67
USD 4250.00
(Single User License)
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 88
USD 3950.00
(Single User License)
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 96
USD 2900.00
(Single User License)
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 126
USD 4900.00
(Single User License)
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 72
USD 4250.00
(Single User License)
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 83
USD 3950.00
(Single User License)
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 71
USD 2900.00
(Single User License)
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published Date: 2024-06-15
Pages: 125
USD 4900.00
(Single User License)
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published Date: 2024-06-15
Pages: 77
USD 2900.00
(Single User License)
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 110
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 67
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 88
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 96
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 126
The global Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 72
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 83
The global market for Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 71
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published: 2024-06-15
Pages: 125
Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) is a potent bone signaling molecule for which there is strong scientific evidence of its ability to induce osteogenesis in the maxillofacial skeleton.
Published: 2024-06-15
Pages: 77
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now